This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Research classified by
Journal of
Economic Literature (JEL) codes Top JEL
/ L: Industrial Organization
/ / L6: Industry Studies: Manufacturing
/ / / L65: Chemicals; Rubber; Drugs; Biotechnology
This topic is covered by the following reading lists: Industrial Sociology (FCT-UNL)
Most recent items first, undated at the end.
2009 Patenting activity in biotechnology and pharmaceuticals: a comparative analysis of the Nordic Countries by Enrico Sorisio [Downloadable!]
2009 How variable is labor input in the Italian manufacturing: the case of the pharmaceutical industry by Lorenzo Carbonari & [Downloadable!]
2009 Investments in Pharmaceuticals Before and After TRIPS by Margaret Kyle & Anita McGahan [Downloadable!]
2009 Technology, Competition and the Time of Entry: Diversification Patterns in the Development of New Drugs by Tatiana Plotnikova [Downloadable!]
2009 Technological Diversity and Future Product Diversity in the Drug Industry by Uwe Cantner & Tatiana Plotnikova [Downloadable!]
2009 Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom by Nathalie Grandfils & Catherine Sermet [Downloadable!]
2009 What’s on the Table? The Doha Round as of August 2009 by Matthew Adler & Claire Brunel & Gary Clyde Hufbauer & Jeffrey J. Schott [Downloadable!]
2009 Surgimiento de actividades de exportación exitosas en México: tres casos específicos by Edgar Aragon & Anne Fouquet & Marcia Campos [Downloadable!]
2009 Surgimiento de actividades de exportación exitosas en Uruguay: cuatro casos específicos by Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta [Downloadable!]
2009 The Emergence of Successful Export Activities in Uruguay: Four Case Studies by Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta [Downloadable!]
2009 Surgimiento de nuevas actividades de exportación en América Latina: el caso de Chile by Manuel Agosin & Claudio Bravo-Ortega [Downloadable!]
2009 The Emergence of New Successful Export Activities in Latin America: The Case of Chile by Manuel Agosin & Claudio Bravo-Ortega [Downloadable!]
2009 The Emergence of Successful Export Activities in Mexico: Three Case Studies by Edgar Aragon & Anne Fouquet & Marcia Campos [Downloadable!]
2009 Price and welfare effects of a pharmaceutical substitution reform by Granlund, David [Downloadable!]
2009 Price and welfare effects of a pharmaceutical substitution reform by Granlund, David
2009 How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French) by Matthieu MONTALBAN ( (GREThA UMR CNRS 5113) [Downloadable!]
2009 How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French) by Matthieu MONTALBAN (GREThA-GRES) [Downloadable!]
2009 Entry in the ADHD drugs market: Welfare impact of generics and me-toos by Farasat A.S. Bokhari & Gary M. Fournier [Downloadable!]
2009 On Pricing and Vertical Organization of Differentiated Products by Shi, Guanming & Chavas, Jean-Paul [Downloadable!]
2009 ¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea? by Costa-Font, Joan & Kanavos, Panos
2009 Small is beautiful: deutsche Chemieunternehmen schrumpfen sich produktiv by Oleg Badunenko [Downloadable!]
2008 The Tunisian Pharmaceutical Sector in Transformation: Inventory of Fixtures and Innovation Prospects by Nejla Yacoub [Downloadable!]
2008 Stratégies d’innovation des firmes des sciences de la vie et appropriation des ressources végétales : processus et enjeux Innovations strategies of firms in life science and appropriation of vegetal resources : process and stakes by Blandine Laperche [Downloadable!]
2008 La lutte anti-blanchiment dans le secteur de l’assurance (the fight against money laundering in the insurance sector) by Éric Vernier & Hubert Delval [Downloadable!]
2008 Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration by Ching, Andrew [Downloadable!]
2008 Firm dynamic governance of global innovation by means of flexible networks of connections by Gay, Brigitte [Downloadable!]
2008 Overcoming Innovation Limits through Outward FDI: The Overseas Acquisition Strategy of Indian Pharmaceutical Firms by Pradhan, Jaya Prakash [Downloadable!]
2008 Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume [Downloadable!]
2008 Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy by Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari [Downloadable!]
2008 Effects of Regulation on Drug Launch and Pricing in Interdependent Markets by Patricia M. Danzon & Andrew J. Epstein [Downloadable!]
2008 Drug price setting and regulation in France by Nathalie Grandfils [Downloadable!]
2008 Genetic Codes of Mergers, Post Merger Technology Evolution and Why Mergers Fail by Alexander Cuntz [Downloadable!]
2008 Generic Substitution by Furu, Kari & Dalen, Dag Morten & Locatelli, Marilena & Strøm, Steinar [Downloadable!]
2008 Multinationals in the Knowledge Economy - a case study of AstraZeneca in Sweden by Andersson, Martin & Johansson, Börje & Karlsson, Charlie & Lööf, Hans [Downloadable!]
2008 The European Socio-Economic Models of a Knowledge-based society. \r\nMain findings and conclusion \r\n by Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA UMR CNRS 5113 and GERPISA) [Downloadable!]
2008 The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions by Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES) [Downloadable!]
2008 Intellectual property rights in agricultural and agro-food biotechnologies to 2030 (© OECD International Futures Programme) by Trommetter, M. [Downloadable!]
2008 On the Effects of Suggested Prices in Gasoline Markets by Riemer P. Faber & Maarten C.W. Janssen [Downloadable!]
2008 Pharmaceutical Research Strategies by Sandra Phlippen & An Vermeersch [Downloadable!]
2008 Do Auctions and Forced Divestitutes increase Competition? by Adriaan R. Soetevent & Marco A. Haan & Pim Heijnen
2008 Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s by Athreye, Suma & Godley, Andrew [Downloadable!]
2008 Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector by Athreye, Suma & Kale, Dinar & Ramani, Shyama V. [Downloadable!]
2008 New Europe's Promise for Life Sciences by Filippov, Sergey & Kalotay, Kalman [Downloadable!]
2008 Facing the Trial of Internationalizing Clinical Trials to Developing Countries: Some Evidence from Mexico by Santiago-Rodriguez, Fernando [Downloadable!]
2008 Selbstselektion statt Personalauswahl? Auslandsentsendungen in der deutschen chemischen Industrie by Heiner Minssen & Susanne Schmidt [Downloadable!]
2008 Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs by Ismo Erkki Linnosmaa [Downloadable!]
2007 Exploring the relationship between scientist human capital and firm performance: The case of biomedical academic entrepreneurs in the SBIR program by Czarnitzki, Dirk & Toole, Andrew A. [Downloadable!]
2007 Restructuring of Energy-intensive Industrial Branches in Romania and Proposals for Industrial Policy Measures by Gábor Hunya & Waltraut Urban & Edward Christie & Michael Landesmann & Constantin Ciupagea & Bianca Pauna & Geomina Turlea [Downloadable!]
2007 Generic entry into a regulated pharmaceutical market by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué [Downloadable!]
2007 Multimarket Contact in Pharmaceutical Markets by Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín [Downloadable!]
2007 The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada? by Antonio Cabrales & Sergi Jiménez-Martín [Downloadable!]
2007 Generic entry into a regulated pharmaceutical market by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué [Downloadable!]
2007 Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques by Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff [Downloadable!]
2007 The Emergence of new Successful Export Activities in Uruguay by Michele Snoeck & Carlos Casacuberta & Rosario Domingo & Héctor Pastori & Lucía Pittaluga [Downloadable!]
2007 Simulaatio lääkekehitysalan kannattavuudesta ja riskeistä by Raine Hermans & Martti Kulvik [Downloadable!]
2007 Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis by Bergmann, Manfred & Schmitz, Andreas & Hayden, Mark & Kosonen, Katri [Downloadable!]
2007 Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks by Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene [Downloadable!]
2007 Financial Risk in the Biotechnology Industry by Joseph H. Golec & John A. Vernon [Downloadable!]
2007 Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration by Glenn Ellison & Sara Fisher Ellison [Downloadable!]
2007 Effects of 'Authorized-Generics' on Canadian Drug Prices by Paul Grootendorst [Downloadable!]
2007 The Relationship among innovative Output, Productivity, and Profitability. A test comparing USPTO and EPO data by Enrico Santarelli & Francesca Lotti [Downloadable!]
2007 Economic Policy in Health Care: Sickness Absence and Pharmaceutical Cost by Granlund, David [Downloadable!]
2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence by Granlund, David & Rudholm, Niklas [Downloadable!]
2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence by Granlund, David & Rudholm, Niklas [Downloadable!]
2007 Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries by Vanessa OLTRA (GREThA) & Maïder SAINT JEAN (GREThA) [Downloadable!]
2007 Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries by Vanessa OLTRA (GREThA-GRES) & Maïder SAINT JEAN (GREThA-GRES) [Downloadable!]
2007 Flexibility in the implementation of intellectual property rights in agricultural biotechnology by Trommetter, M. [Downloadable!]
2007 Downsizing in German Chemical Manufacturing Industry during the 1990s: Why Small Is Beautiful? by Oleg Badunenko [Downloadable!]
2007 The strategic interaction between firms and formulary committees: Effects on the prices of new drugs by María García-Alonso & Begoña García-Mariñoso [Downloadable!]
2007 Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation? by Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås [Downloadable!]
2007 Multimarket Contact in Pharmaceutical Markets by Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín [Downloadable!]
2007 The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada? by Antonio Cabrales & Sergi Jiménez-Martín [Downloadable!]
2007 What is "Business Development"? - The Case of Biotechnology by Sonja Kind & Dodo zu Knyphausen-Aufseß [Downloadable!]
2006 Knowledge-sourcing strategies for cross-disciplinarity in bionanotechnology by Isamel Rafols & Martin Meyer [Downloadable!]
2006 Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmasta by Terttu Luukkonen & Mari Maunula [Downloadable!]
2006 Adaption of New Technologies and Costs of Health Care by Martti Kulvik & Ismo Linnosmaa & Raine Hermans [Downloadable!]
2006 `Coaching´ Small Biotech Companies into Success: The Value-adding Function of VC by Terttu Luukkonen & Mari Maunula [Downloadable!]
2006 The Perceived Value-added of Venture Capital Investors. Evidence from Finnish Biotechnology Industry by Mari Maunula [Downloadable!]
2006 Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaan by Hannu Hernesniemi & Martti Kulvik [Downloadable!]
2006 A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence by Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene [Downloadable!]
2006 A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment by Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene [Downloadable!]
2006 Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies by Pradhan, Jaya Prakash [Downloadable!]
2006 Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises? by Pradhan, Jaya Prakash & Alakshendra, Abhinav [Downloadable!]
2006 Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research by Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson [Downloadable!]
2006 Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers by Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout [Downloadable!]
2006 Did Medicare Induce Pharmaceutical Innovation? by Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn [Downloadable!]
2006 R&D in the Belgian Pharmaceutical Sector by Helga De Doncker [Downloadable!]
2006 Jüngere Entwicklungen auf dem Risikokapitalmarkt für Biotechnologie in Deutschland by Simeon Schudy [Downloadable!]
2006 Indian Patent Policy and Publich Health : implications from the Japanese Experience by Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko [Downloadable!]
2006 The Pharmacia Story of Entrepreneurship and as a Creative Technical University - An Experiment in Innovation, Organizational Break Up and Industrial Renaissance by Eliasson, Gunnar & Eliasson, Åsa [Downloadable!]
2006 Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices? by Oleg Badunenko & Michael Fritsch & Andreas Stephan [Downloadable!]
2006 Indian Pharma Within Global Reach? by Gehl Sampath, Padmashree [Downloadable!]
2006 Rough Road to Market: Institutional Barriers to Innovations in Africa by Oyelaran-Oyeyinka, Banji & Gehl Sampath, Padmashree [Downloadable!]
2006 India's product patent protection regime: Less or more of "pills for the poor"? by Gehl Sampath, Padmashree [Downloadable!]
2006 The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan by Mahlich, Jörg C. & Roediger-Schluga, Thomas [Downloadable!]
2006 Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers' by Gehl Sampath, Padmashree [Downloadable!]
2006 The Dye Famine and its Aftermath: Knowledge Diffusion and Entry by Genesove, David [Downloadable!]
2006 Reference Pricing of Pharmaceuticals by Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume [Downloadable!]
2006 La propriété intellectuelle dans les biotechnologies agricoles : quels enjeux pour quelles perspectives ? by Michel Trommetter [Downloadable!]
2006 Comment favoriser l'innovation dans le secteur pharmaceutique : brevets et/ou récompenses ? by Paul Belleflamme & Tanguy van Ypersele [Downloadable!]
2005 Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D by Toole, Andrew A. [Downloadable!]
2005 Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry by Fier, Andreas & Heneric, Oliver [Downloadable!]
2005 Functional Foods In The European Union: An Overview Of The Sector'S Main Issues by Alessandra CASTELLINI & Maurizio Canavari & Carlo Pirazzoli [Downloadable!]
2005 Production of a New Drug: A Sequential Investment ProcessUnder Uncertainty by Marcello Basili & Roberto Renò & Carlo Zappia [Downloadable!]
2005 Technological Characteristics and R&D Alliance Form: Evidence from the U.S. Biotechnology Industry by Xia Wang [Downloadable!]
2005 Phases of Imitation and Innovation in a North-South Endogenous Growth Model by Daniel Rais & Jonathan Goldman [Downloadable!]
2005 “Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets by Michael R. Ward & David Reiffen [Downloadable!]
2005 Innovation Paths of Estonian Biotechnology by Tõnis Mets [Downloadable!]
2005 Consequences of the IPPC-directive’s BAT requirements for abatement costs and emissions by Jan Larsson and Kjetil Telle [Downloadable!]
2005 The Growth of Business Firms: Theoretical Framework and Empirical Evidence by Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene [Downloadable!]
2005 Trips and Patenting Activity: Evidence from the Indian Pharmaceutical Industry by Alka Chadha [Downloadable!]
2005 Product cycles, innovation and exports: A study of Indian pharmaceuticals by Alka Chadha [Downloadable!]
2005 Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending by Joseph Golec & Shantaram Hegde & John A. Vernon [Downloadable!]
2005 Socio-economic Impact of Nanoscale Science: Initial Results and NanoBank by Lynne G. Zucker & Michael R. Darby [Downloadable!]
2005 Parallel Imports, Drag Price Control and Pharmaceutical Innovation by Ken Tabata & Testuya Shinkai & Satoru Tanaka & Makoto Okamura [Downloadable!]
2005 Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases by Ito, Banri & Yamagata, Tatsufumi [Downloadable!]
2005 Testing Collusive Prices In A Multimarket Context: The European Case Of Vitamin C by Jacint Balaguer & Ezequiel Uriel Jiménez & Vicente Orts [Downloadable!]
2005 Start-ups, firm growth and the consolidation of the French biotech industry by Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C. [Downloadable!]
2005 Knowledge and Productivity in the World's Largest Manufacturing Corporations Level:Panel Data analysis on Compustat and Patent data by Lionel Nesta [Downloadable!]
2005 Empirical tests of optimal cognitive distance by Wuyts, Stefan & Colombo, Massimo G. & Dutta, Shantanu & Nooteboom, Bart [Downloadable!]
2005 Density and strength of ties in innovation networks : an analysis of multi-media and biotechnology by Gilsing, Victor A. & Nooteboom, Bart [Downloadable!]
2005 The relationship of drug reimbursement with the price and the quality of pharmaceutical innovations by María García-Alonso & Begoña Garcia-Mariñoso [Downloadable!]
2005 Direct to Consumer Advertising in Pharmaceutical Markets by Kurt R. Brekke & Michael Kuhn [Downloadable!]
2005 Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales by Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff [Downloadable!]
2004 Biotechnology in New Zealand by Dan Marsh [Downloadable!]
2004 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain by Joan Costa & Jaume Puig [Downloadable!]
2004 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain by Joan Costa & Jaume Puig [Downloadable!]
2004 Estudios de competitividad sectoriales. Industria manufacturera by María Inés Terra & Gustavo Bittencourt & Rosario Domingo & Carmen Estrades & Gabriel Katz & Alvaro Ons & Héctor Pastori [Downloadable!]
2004 Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency by Drusilla K. Brown & George Norman [Downloadable!]
2004 Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry by Pablo D'Este Cukierman [Downloadable!]
2004 FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry by Pradhan, Jaya Prakash [Downloadable!]
2004 Market Structure and Drug Innovation by Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
2004 Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure by Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
2004 Preferential attachment and growth dynamics in complex systems by Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene [Downloadable!]
2004 The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program by Frank R. Lichtenberg [Downloadable!]
2004 Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process by Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck [Downloadable!]
2004 Vertical Product Differentiation, Market Entry, and Welfare by Reisinger, Markus [Downloadable!]
2004 Competence in Health Care - An Industrial Systems Analysis Using Competence Bloc Theory to Compare European and US Health Care by Eliasson, Gunnar & Eliasson, Åsa [Downloadable!]
2004 The Norwegian market for pharmaceuticals and the non-mandatory substitution reform of 2001: the case of enalapril by Razzolini, Tiziano [Downloadable!]
2004 The Origin and Location of Entrants in the Evolution of the U.S. Tire Industry by G. Buenstorf & S. Klepper [Downloadable!]
2004 A Dynamic Oligopoly Structural Model for the Prescription Drug Market After Patent Expiration by Andrew Ching [Downloadable!]
2004 Price Regulation and Competition in Japanese Pharmaceutical Market by Tomofumi & Anegawa
2004 Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo? by Joan Ramon Borrell Arque [Downloadable!]
2004 Price Competition in Pharmaceuticals: The Case of Anti-infectives by Steven N. Wiggins & Robert Maness [Downloadable!]
2004 La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies by Marc-Hubert Depret & Abdelillah Hamdouch [Downloadable!]
2003 International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies by Margaret Levenstein & Valerie Suslow & Lynda Oswald [Downloadable!]
2003 Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy by Antonio Cabrales [Downloadable!]
2003 Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy by Antonio Cabrales [Downloadable!]
2003 Optimal Intellectual Property Rights Exhaustion and Humanitarian Assistance during a National Health Emergency by Drusilla K. Brown & George Norman [Downloadable!]
2003 The Knowledge Bases of the World's Largest Pharmaceuticals Groups: what do Patent Citations to Non-Patent Literature Reveal? by Stefano Brusoni & Paola Criscuolo & Aldo Geuna [Downloadable!]
2003 Intangible Assests and Market Value: Evidence from Biotechnology Firms by Lionel Nesta & Pier-Paolo Saviotti [Downloadable!]
2003 Reverse Technology Transfer: A Patent Citation Analysis of the European Chemical and Pharmaceutical Sectors by Paola Criscuolo [Downloadable!]
2003 The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing by Stavins, Robert & Snyder, Lori & Miller, Nolan [Downloadable!]
2003 Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry by Pradhan, Jaya Prakash [Downloadable!]
2003 On Size and Growth of Business Firms by De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio [Downloadable!]
2003 Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke: A Study of 12 OECD Countries by Michael Dickson & Stéphane Jacobzone [Downloadable!]
2003 Uncertainty in the Generic Versus Brand Name Prescription Decision by Hellström, Jörgen & Rudholm, Niklas [Downloadable!]
2003 Titanium Implants – A Comparison of a Swedish and an Ohio Firm by Fridh, Ann-Charlotte [Downloadable!]
2003 The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing by Lori Snyder & Nolan Miller & Robert Stavins [Downloadable!]
2003 Globalisation and Its Impact on Competitiveness: the Case of the British and German Pharmaceutical Industry by Christel Lane & Jocelyn Probert [Downloadable!]
2003 Reference prices: The Spanish way by Jorge Mestre [Downloadable!]
2002 Erfolgsabhängige Vergütung: Ein sicherer Weg zur Steigerung der Leistung von Top-Managern? by Zwick, Thomas & Wolf, Elke & Beblo, Miriam [Downloadable!]
2002 Does New Zealand have an Innovation System for Biotechnology? by Dan Marsh [Downloadable!]
2002 Economic Insights and Deficits in European Biotechnology Patent Policy by Gilroy, Bernard Michael & Vollpert, Tobias [Downloadable!]
2002 A Comparison of U.S. and European University-Industry Relations in the Life Sciences by Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W. [Downloadable!]
2002 Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health" by Frank R. Lichtenberg & Suchin Virabhak [Downloadable!]
2002 Benefits and Costs of Newer Drugs: An Update by Frank Lichtenberg [Downloadable!]
2002 Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry by Marín Uribe, Pedro Luis & Siotis, Georges [Downloadable!]
2002 Biotecnologia: corporações, financiamento da inovação e novas formas organizacionais by Silveira, José Maria F. J. da [Downloadable!]
2001 Do court-ordered breakups spur innovation? by Leon Taylor [Downloadable!]
2001 Modern Biotechnology in New Zealand: Further Analysis of Data from the Biotechnology Survey 1998/99 by Dan Marsh [Downloadable!]
2001 On Firm Growth in Networks by Riccaboni, Massimo & Pammolli, Fabio [Downloadable!]
2001 An Empirical Model of Heterogeneous Consumer Search for Retail Prescription Drugs by Alan T. Sorensen [Downloadable!]
2001 The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey by Frank R. Lichtenberg [Downloadable!]
2001 Global/local articulation in industrial models for phamaceuticals, automobile and aeronautics (In French) by Marie-Claude BÉLIS-BERGOUIGNAN (IFREDE-E3i) & Vincent FRIGANT (IFREDE-E3i) & Damien TALBOT (LEREPS) [Downloadable!]
2001 Innovation et marche financiers: l'impact des avancees therapeutiques sur les rentabilites boursieres des firmes by Campart, S. & Pfister, E.
2001 Research Incentives in Competing Markets: A Model of the Development of New Vaccines by Rey, P.
2001 The World Trade Organization and Publicly Funded Healthcare in Canada by Ostry, A.
2001 Buying Science, Selling Drugs by Evans, R.G. & Morgan, S.G. & Barer, M.L.
2001 The Self-Organisation of Strategic Alliances by Andreas Pyka & Paul Windrum [Downloadable!]
2001 Innovation Networks in the Biotechnology-Based Sectors by Andreas Pyka & Paolo Saviotti [Downloadable!]
2000 Fostering Innovation in a Small Open Economy: The Case of the New Zealand Biotechnology Sector by Dan Marsh [Downloadable!]
2000 Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data by Erik Biørn, Kjersti-Gro Lindquist and Terje Skjerpen [Downloadable!]
2000 The Nature and the Extent of the Market for Technology in Biopharmaceuticals by Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
2000 Global Competitiveness in Pharmaceuticals: A European Perspective by Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio [Downloadable!]
2000 Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs by Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay [Downloadable!]
2000 Entry and the Number of firms in the Swedish Pharmaceuticals Market by Rudholm, Niklas [Downloadable!]
2000 How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s by Streb, J.
2000 How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s by Streb, J.
2000 Heternenous Labor Demand and Aggregate Job Flows. Specification, Estimation and Testing with French Data by Fairise, X. & Feve, P.
2000 L'utilisation des notions de confiance et de proximite dans l'etude des processus de R&D pharmaceutiques by Perrochon, D. & Lebert, D.
2000 Coalitions industrielles, reseaux de firmes et dynamiques de concurrence-cooperation dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique by Hamdouch, A. & Depret, M.-H.
2000 Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening by Franco Malerba & Luigi Orsenigo [Downloadable!]
2000 Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry by Nicola Lacetera [Downloadable!]
2000 The determinants of pharmaceutical research and development expenditures by Henry Grabowski & John Vernon [Downloadable!]
1999 An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes by Michael M. Hopkins [Downloadable!]
1999 Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs by Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay [Downloadable!]
1999 How to Win Schumpeterian Competition: Technological Transfers in the German Plastics Industry from the 1930s to the 1970s by Jochen Streb [Downloadable!]
1998 Demand for Prescription Drugs: The Effects of Managed Care Pharmacy Benefits by Rika Onishi Mortimer [Downloadable!]
1998 Characterizing Informational Barriers To Entry In The Anti-Ulcer Drug Market by Matthew Shum [Downloadable!]
1998 Random Coefficients and Unbalanced Panels: An Application on Data from Norwegian Chemical Plants by Erik Biørn, Kjersti-Gro Lindquist and [Downloadable!]
1998 The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"? by Jean O. Lanjouw [Downloadable!]
1998 The Impact of Generic Competition on Brand Name Market Shares - Evidence from Micro Data by Aronsson, Thomas & Bergman, Mats & Rudholm, Niklas [Downloadable!]
1998 The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data by Aronsson, Thomas & Bergman, Mats A. & Rudholm, Niklas [Downloadable!]
1998 Evolutionary innovations: learning, entrepreneurship and the dynamics of the firm by Maureen McKelvey [Downloadable!]
1997 The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules by Fiona M. Scott Morton [Downloadable!]
1997 Royalty rates, sub licensing considerations and joint ventures by Elli Malki [Downloadable!]
1997 The economic sense of royalty rates by Elli Malki [Downloadable!]
1997 Intellectual property and the valuation of biotechnology by Elli Malki [Downloadable!]
1997 Entry Decisions in the Generic Pharmaceutical Industry by Fiona M. Scott Morton [Downloadable!]
1997 The Objectives of the FDA's Office of Generic Drugs by Fiona Scott Morton [Downloadable!]
1997 Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry by White, S. & Liu X. & Yoshihara, H.
1997 Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective by White, S.
1997 Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry by Liu, X. & White, S.
1997 Outsourcing of Research by Pharmaceutical and Biotechnology Firms by Tapon, F. & Thong, M.
1997 The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"? by Lanjouw, J.O.
1997 The Pharmaceutical Industry in India and Hungary. Policies, Institutions, and Technological Development by Felker, G. & Chaudhuri, S. & Gyorgy, K. & Goldman, M.
1997 Medicinal Plants, Rescuing Global Heritage by Lambert, J. & Srivastava, J. & Vietmeyer, N.
1997 Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry by White, S. & Liu X. & Yoshihara, H.
1997 Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective by White, S.
1997 Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry by Liu, X. & White, S.
1997 Les prestataires logistiques et la distribution pharmaceutique. Les barrieres a l'entree: vitres blindees ou glaces sans tain by Mattiuzzo, N. & Le Goff, J.
1997 Merger, Retionalisation and the "High Commitment" Organisation by Randle, K.
1997 Outsourcing of Research by Pharmaceutical and Biotechnology Firms by Tapon, F. & Thong, M.
1997 Israel: Secteur de l'equipement medical by Theriault, V.
1997 Chili:Secteur de l'equipement medical by Froissart, S.
1997 Belgique: Secteur de l'equipement medical haute technologie by Froissart, S.
1997 Thailande: Secteur de l'equipement medical by Froissart, S.
1997 Malaisie: Secteur de l'equipement medical de haute technologie by Froissart, S.
1996 Rewarding Failure: Performance Related Pay in a Pharmaceutical research and Development Company by Randle, K.
1995 Generics and New Goods in Pharmaceutical Price Indexes by Zvi Griliches & Iain Cockburn [Downloadable!]
1995 R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry by Joseph A. Dimasi & Grabowski, Henry G. & Vernon, John
1995 Do Other Firms Matter in Oligopolies? by Haskel, Jonathan & Scaramozzino, Pasquale [Downloadable!]
1995 Genotyping by Combinatorial Optimization Techniques by Lancia, G.
1995 The transmission of information in the transacting of primary products: the case of quality improvement in Thailand's natural rubber production by Shigetomi, Shinichi [Downloadable!]
1994 Fast Growing Small Entrepreneurial Firms and their Venture Capital Backers: an Applied Principal-Agent Analysis by Gavin C Reid [Downloadable!]
1994 The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry by Ernst R. Berndt & Linda Bui & David Reiley & Glen Urban [Downloadable!]
1993 Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry by Rebecca Henderson & Iain Cockburn [Downloadable!]
Direct-to-Consumer Advertising in Pharmaceutical Markets by Kurt R Brekke & Michael Kuhn [Downloadable!]
This page was last updated on 2009-11-8.
This information is provided to you by IDEAS at the Department of Economics , College of Liberal Arts and Sciences , University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics .